Skip to content

Drug prices are too high. What is Congress trying to do about it?

Chairman Charles E. Grassley, right, and ranking member Sen. Ron Wyden are seen before a Senate Finance Committee on drug pricing in America on February 26, 2019. (Tom Williams/CQ Roll Call)
Chairman Charles E. Grassley, right, and ranking member Sen. Ron Wyden are seen before a Senate Finance Committee on drug pricing in America on February 26, 2019. (Tom Williams/CQ Roll Call)

Both the House and the Senate have competing bills aimed at addressing the rising costs of prescription drugs, a legislative priority backed by President Donald Trump.

But what would these various proposals accomplish, and how likely is it they’ll be signed into law?

[jwp-video n=”1″]

Recent Stories

Capitol Lens | Feeling the Bern

Capitol Ink | Power lift

How backlash to the pandemic helped shape Trump’s health picks

Deck the Hill with books aplenty: Capitol insiders share their favorite reads of 2024

Democrats’ competing postmortems leave out history — and the obvious

Kamala Harris lost, but how weak of a candidate was she?